Relaxation |
|
|
Clinical Trial: Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
This study is currently recruiting patients.
|
Purpose
| Condition | Intervention |
|---|---|
| Attention Deficit Disorder with Hyperactivity | Behavior: Cognitive Behavioral Therapy Behavior: Relaxation techniques and education about ADHD |
MedlinePlus related topics: Attention Deficit Disorder with Hyperactivity
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Efficacy of CBT for Residual ADHD in Adults
Expected Total Enrollment: 72
Study start: September 2004
ADHD, previously believed to be a disorder of childhood, affects as many as 5 percent of adults. Adults with ADHD are at high risk for academic and occupational underachievement, relationship difficulties, and reduced quality of life. This study will determine whether CBT is more effective than ADHD education and relaxation techniques in treating adults with ADHD.
Participants will be randomly assigned to receive 12 to 15 weekly sessions of either CBT or training in which they will learn relaxation techniques and receive detailed information about ADHD. Questionnaires will be used to assess participants'''' ADHD symptoms at study entry and at study completion.
Study hypothesis: CBT is a more efficacious treatment for adult ADHD than education and relaxation techniques.
Eligibility
Inclusion Criteria:
- Diagnosis of adult ADHD of at least mild clinical severity (CGI score of 3 or greater)
- Stabile on medications for adult ADHD for at least 2 months -Between 18 and 65 years old -Be able to give informed consent and comply with study procedures
Exclusion Criteria:
- Moderate to severe major depression, clinically signficant panic disorder (CGI for depression or panic greater than 4), bipolar disorder, organic mental disorders, psychotic disorders, or pervasive developmental disorders -Active suicidality (HAM-D suidicality item rater 3 or 4)
- Current substance abuse or dependence
- IQ less than 90
- Suicide risk
- Prior participation in cognitive behavioral therapy
Location and Contact Information
Susan Sprich, PhD 617-726-5991 ssprich@partners.org
Massachusetts
Massachusetts General Hospital, Boston, Massachusetts, 02114, United States; Recruiting
Susan Sprich, PhD 617-726-5991 ssprich@partners.org
Steve A. Safren, PhD, Principal Investigator, Fenway Community Health
Susan Sprich, PhD, Study Director, Partners Health Organization
More Information
Record last reviewed: July 2005
Last Updated: July 21, 2005
Record first received: July 11, 2005
ClinicalTrials.gov Identifier: NCT00118911
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-07-26

Not Signed In -

